New Delhi | 14th April 2020: In a bid to defeat coronavirus from further spreading its wings, Medikabazaar has instituted a COVID Combat Collaborative Platform on its website. The single platform connects COVID buyers, COVID sellers and COVID experts to facilitate timely and sufficient supply of medical essentials, vital for life-saving or preventive healthcare purposes against the pandemic. The step is aimed at eliminating misinformation regarding the demand-supply of essential medical goods, at all ends.
The medtech company has established a single-point platform on their website to facilitate smooth communication regarding the supplies of medical equipment and commodities, amidst the mandated lockdown. The initiative directly connects sellers and buyers of the medical goods pertaining to coronavirus such as ventilators, hand-sanitizers, thermometers, personal protection equipment kit, 3 ply masks, goggles, and more.The efforts are made by the company to collaborate with the customers & suppliers to help supply hospitals, health centres, quarantine centres, pharmacies and other screening and medical facilities across the private and public sectors. Interested buyers/sellers can join the network through their website https://www.medikabazaar.com/.
The easy-to-use interface of the platform displays the products available at the seller’s end and allows the buyer to order them directly in the desired quantity by filling in a simple form. Medikabazaar’s COVID Collaboration Platform Team contacts the user within 24 hours to assist on the subject and provide active solutions.
Speaking about the initiative, Mr. Vivek Tiwari, Founder and CEO, Medikabazaar, said, “Through COVID combat Collaboration Platform, we are looking to collaborate with all suppliers, healthcare institutions and industry experts to come together and help each other fight the deadly virus. The idea is to reduce confusion over demand and supply of COVID medical supplies in such crucial times, wherein any misinformation can be detrimental to human life.”